iShares U.S. Pharmaceuticals ETF (IHE)
| 163.63 BATS BZX Real-Time Price As of 12:11pm ET |  +0.52 / +0.32%Today’s Change | 115.53 Today|||52-Week Range 165.70 | +2.19% Year-to-Date |
Investment Objective
The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The fund is non-diversified.
Latest IHE News
| Craving Healthcare: A Beginner's Guide And My 7 Picks Jul 31 / Seeking Alpha - Paid Partner Content |
Performance
| 1 month | +6.28% | 3 years | +3.96% | |
| 3 months | +8.54% | 5 years | -0.44% | |
| 1 year | +18.33% | Since inception | +10.23% |
Data through 08/06/2020
Quote Details
| Previous close | $163.11 |
| Open day’s range | 163.63 – 163.63 |
| Net asset value (NAV) | 164.32 (08/05/2020) |
| Daily volume | 2,126 |
| Average volume (3 months) | 18,164 |
Data as of 12:11pm ET, 08/07/2020
Peer Comparisonvs. Health ETFs
| IHE | Category | |
|---|---|---|
| Performance 5-yr return | -0.44% | +6.57% |
| Expense Gross exp ratio | 0.42% | 1.22% |
| Risk 5 year sharpe ratio | -0.05 | 0.37 |
| Net assets | $339.2M | $3.5B |
| Average market cap | $47.9B | $40.8B |
| Average P/E | 24.7 | 27.0 |
| Dividend / Share | -- | 0.28% |
Competitors
| VHT Vanguard Health Care Index Fund ETF Shar... |
| FHLC Fidelity MSCI Health Care Index ETF |
| IHI iShares U.S. Medical Devices ETF |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 98.99% |
| Consumer goods | 1.01% |
| Business service | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| JNJ Johnson & Johnson | 21.93% |
| MRK Merck | 18.78% |
| CTLT Catalent Inc | 5.46% |
| HZNP Horizon Therapeutics PLC | 5.21% |
| ZTS Zoetis Inc | 4.82% |
| PFE Pfizer | 4.76% |
| LLY Eli Lilly and Co | 4.42% |
| BMY Bristol-Myers Squibb | 4.34% |
| ELAN Elanco Animal Health Inc | 4.21% |
| MYL Mylan NV | 3.72% |
